A critical re-evaluation of the regression model specification in the US D1 EQ-5D value function by Rand-Hendriksen, Kim et al.
RESEARCH Open Access
A critical re-evaluation of the regression model
specification in the US D1 EQ-5D value function
Kim Rand-Hendriksen
1,2*, Liv A Augestad
1 and Fredrik A Dahl
1
Abstract
Background: The EQ-5D is a generic health-related quality of life instrument (five dimensions with three levels, 243
health states), used extensively in cost-utility/cost-effectiveness analyses. EQ-5D health states are assigned values on
a scale anchored in perfect health (1) and death (0).
The dominant procedure for defining values for EQ-5D health states involves regression modeling. These regression
models have typically included a constant term, interpreted as the utility loss associated with any movement away
from perfect health. The authors of the United States EQ-5D valuation study replaced this constant with a variable,
D1, which corresponds to the number of impaired dimensions beyond the first. The aim of this study was to
illustrate how the use of the D1 variable in place of a constant is problematic.
Methods: We compared the original D1 regression model with a mathematically equivalent model with a
constant term. Comparisons included implications for the magnitude and statistical significance of the coefficients,
multicollinearity (variance inflation factors, or VIFs), number of calculation steps needed to determine tariff values,
and consequences for tariff interpretation.
Results: Using the D1 variable in place of a constant shifted all dummy variable coefficients away from zero by the
value of the constant, greatly increased the multicollinearity of the model (maximum VIF of 113.2 vs. 21.2), and
increased the mean number of calculation steps required to determine health state values.
Discussion: Using the D1 variable in place of a constant constitutes an unnecessary complication of the model,
obscures the fact that at least two of the main effect dummy variables are statistically nonsignificant, and
complicates and biases interpretation of the tariff algorithm.
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Background
T h eE Q - 5 D ,ag e n e r i ci n s t r u m e n tf o rm e a s u r i n gh e a l t h -
related quality of life (HRQoL), is used extensively in
cost-utility/cost-effectiveness analyses [1,2]. The EQ-5D
measures health along five dimensions (mobility, self-
care, usual activities, pain/discomfort, and anxiety/
depression). Each of these dimensions can be described
at three levels of functioning, corresponding to (1) no
problems, (2) some problems, and (3) extreme problems.
This gives a total of 243 possible combinations, or health
states. Specific health states are often referred to using a
five-digit number, corresponding to the level of
functioning for the five dimensions in the previously pre-
sented order. Thus, 11111 refers to the best state, and
33333 refers to the worst. To allow calculations and com-
parisons involving different impairments of health, all
EQ-5D health states are assigned values using a common
metric, usually such that perfect health has a defined
v a l u eo f1 ,a n dd e a t hh a sad e f i n e dv a l u eo f0 .S i n c eE Q -
5D health states (with the exception of state 11111) do
not have intrinsic values on this common scale, such
tariffs of values have usually been set through national
valuation studies that ask the general population to value
EQ-5D health states in relation to perfect health and
death [3].
The United States EQ-5D valuation study from 2003
[4] brought improvements to EQ-5D valuation metho-
dology by bringing in more complex sampling and
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representativeness and has partially superseded its 1993
British predecessor [5] as the EQ-5D valuation study of
reference. Several papers have been published discussing
differences and similarities between the US and United
Kingdom valuation studies [6-8]. Since directly valuing
all EQ-5D health states was considered impractical, EQ-
5D valuation studies have typically elicited values for a
subset of the EQ-5D health states, and values for the
full set have been assigned using regression modeling,
making the regression procedure and model crucial
components of the EQ-5D system [5].
T h ea u t h o r so ft h eU Sv a l u a t i o ns t u d y[ 4 ]p e r f o r m e d
numerous advanced statistical analyses to determine the
best regression method and specification to predict US
tariff values for the EQ-5D system. The chosen regression
model differed from the preceding British model [5] in
several ways, the most important of which were the lack of
a constant signifying any movement away from perfect
health and the inclusion of an ordinal value “D1,” signify-
ing the number of movements away from perfect health,
beyond the first. The authors argued that replacing the
constant with the D1 variable improved the model because
“... In previous valuation studies, the constant term has
been interpreted as a measure of any movement away
from perfect health (i.e., a level 2 or 3 in any dimension).
Including a constant term, however, yields a predicted
value of < 1.0 for full health and complicates estimation of
the marginal effects for the dummy variables that repre-
sent the EQ-5D descriptive system. [...] Its [the D1 vari-
able’s] use in place of a constant yielded a predicted value
of 1.0 for full health, had no impact on the predicted
values for other states, and allowed us to estimate directly
the marginal effects of the main effect dummy vari-
ables...”[4] (p. 208, fourth paragraph, brackets inserted).
The EuroQol group has recently released official ver-
sions of the new EQ-5D-5L [9], where each dimension
can be described at five levels, as opposed to the pre-
vious three. It is likely that a number of new national
tariffs will be published over the next couple of years,
both for countries for which EQ-5D-3L tariffs exist, and
for countries without any EQ-5D tariffs.
The aim of this study was to illustrate how the use of the
D1 variable in place of a constant is problematic, because
it constitutes an unnecessary complication of the regres-
sion model, obscures the fact that three of the main effect
dummy variables are statistically nonsignificant, and com-
plicates and biases interpretation of the tariff algorithm.
Methods
Data
Analyses were performed directly on the published D1
regression model, the D1 tariff algorithm, and the pre-
dicted tariff values for all 243 health states [4].
The D1 variable, model, and tariff values
In the literature, “D1” refers to the D1 variable, the regres-
sion model using the D1 variable, and the tariff algorithm
based on the regression model. To disambiguate this, we
will refer to the original D1 regression model as D1o (“o”
for original) and specify whether we are referring to vari-
ables in the model or to their respective coefficients. D1
will refer to the variable in the model. The D1o regression
model consists of 10 dummies (M2, S2, U2, P2, A2, M3,
S3, U3, P3, and A3) corresponding to the five dimensions
at level 2 (moderate problems) and 3 (extreme problems).
The variables I2 and I3 correspond to the number of
dimensions at levels 2 and 3, beyond the first; the squares
of I2 and I3 are called I22 and I32; and the D1 variable sig-
nifies the number of dimensions beyond the first, not at
level 1. The variable I2 was statistically nonsignificant in
the calculation of tariff values and was excluded from the
final modeling. Model calculations were performed on dis-
utilities; 1 - time trade-off (TTO) values were such that 0
corresponded to health state 11111 (all five dimensions at
level 1), and 1 corresponded to the defined value of death.
Column one of Table 1 lists the published US D1 tariff
a n ds t a n d a r de r r o r s( S E )f o rt h ec o e f f i c i e n t s .U s i n gt h i s
tariff algorithm, values for each health state can be calcu-
lated as 1, the value of perfect health, minus the predicted
disutility of the health state.
Handling the constant and state 11111
In the TTO method used for valuing health states in the
US valuation study, “death” and EQ-5D state 11111 (per-
fect health) function as anchors for valuing the other health
states. In order to be in line with the quality-adjusted life
Table 1 D1 model recalculation, tariff, and variance
inflation factors (VIFs)
D1o D1c
Parameter Coeff. (SE) VIF Recalculation Coeff. (SE) VIF
Constant N/A N/A -D1 -.140 (.010) N/A
D1 .140 (.010) 113.184 D1-D1 N/A N/A
M2 -.146 (.008) 5.336 M2+D1 *-.006 (.006) 1.913
S2 -.175 (.008) 5.336 S2+D1 -.035 (.007) 1.913
U2 -.140 (.008) 5.336 U2+D1 *-.000 (.006) 1.913
P2 -.173 (.008) 5.336 P2+D1 -.032 (.007) 1.913
A2 -.156 (.008) 5.336 A2+D1 -.016 (.007) 1.913
M3 -.558 (.016) 5.038 M3+D1 -.418 (.012) 3.591
S3 -.471 (.016) 5.038 S3+D1 -.331 (.013) 3.591
U3 -.374 (.013) 5.038 U3+D1 -.234 (.010) 3.591
P3 -.537 (.020) 5.038 P3+D1 -.397 (.015) 3.591
A3 -.450 (.015) 5.038 A3+D1 -.310 (.012) 3.591
I3 .122 (.018) 38.529 I3 .122 (.014) 21.211
I2 squared -.011 (.002) 5.384 I22 -.011 (.002) 3.893
I3 squared .015 (.003) 9.773 I32 .015 (.003) 7.066
* Statistically nonsignificant (p < .05).
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fixed value of 1, and death was given a fixed value of 0.
Since regression was performed using disutilities, and only
impaired health states were valued, the intercept term (if
allowed) represented an estimate of the common utility
loss associated with all measured health states. Interpreted
as a constant, this intercept clearly does not apply to state
11111. Therefore, state 11111 should be handled in one of
two mutually exclusive ways. It could be considered either
as outside the scope of the prediction algorithm, since it is
given the axiomatic value of 1. In this case, the intercept
should be interpreted as a constant applying to all health
states within the prediction scope. Or state 11111 could be
included in the scope of prediction, in which case the inter-
cept should be interpreted as a nonconstant parameter
applying to all health states except 11111. In either case,
the predicted value for state 11111 would be 1. For the
statement “Including a constant, however, yields predicted
value of < 1.0 for full health” to hold true, the state must
be considered inside the scope of prediction, while the
intercept is interpreted as a constant.
In this paper, we considered the given value of state
11111 to be axiomatic, and therefore, outside of the scope
of the tariff prediction. We interpreted the intercept as a
constant within the scope of the 242 remaining EQ-5D
health states.
Analysis
D1c and statistical significance
We formulated the mathematical equivalent of the D1o
model, including a constant and excluding the D1 variable,
hereafter referred to as the D1c model (“c” for constant).
Using the D1c regression model on the US valuation data,
we illustrate how the choice of model influences the
apparent statistical significance of the different dummy
variable coefficients.
Multicollinearity
The D1o and D1c models are mathematically identical in
terms of explained population variance and predicted
values for all EQ-5D health states. However, different pre-
dictors result in different degrees of multicollinearity, a
measure of the correlation between (and thereby, redun-
dancy of) the predictors in the model. Multicollinearity is
usually measured in terms of variable inflation factors
(VIFs) for their predictors [11]. VIFs are readily available
as optional output when performing regression modeling
in most statistical software packages (SPSS/PASW,
STATA, SAS, R, etc.). However, direct calculation of VIFs
is also relatively straightforward, and can be done in two
steps.
To calculate the VIF for any specific predictor variable
in a regression model, the first step is to run a regression
with the predictor in question as the dependent variable
and all other predictors as independent variables. From
this regression, we are only interested in the coefficient
of determination (the R
2 term). The VIF equals 1/(1-R
2).
The square root of the VIF is a measure of how much
larger the standard error term for the variable in question
is as compared to the size it would have if the model was
specified in such a way that the variable was uncorrelated
with the other variables in the model.
Ideally, VIF values should be low, and while rules of
thumb should be used with caution, cut-offs of 5, 10, and
sometimes 30 have been suggested as indicating proble-
matic levels of multicollinearity [11]. The VIFs are deter-
mined entirely by the correlation between the predictors.
We calculated each VIF score of the D1o and D1c models
within the definition space of the 242 EQ-5D health states.
Simplicity of interpretation
For the purpose of comparison, we divided the 242 EQ-5D
health states into three groups: the 10 health states
describing impairment in only one dimension, the 40
health states with impairments in two dimensions, and the
192 states with impairments in three or more dimensions.
We considered the number of calculation steps necessary
for the three groups of health states based on the two tariff
models (D1o and D1c) and the implications for interpreta-
tion. The number of calculation steps necessary is rela-
tively unimportant in most applications, but we include
these analyses because the authors of the US valuation
study argue for the simplicity of calculation in their paper.
We also compared the calculation steps based on the D1o
and D1c models for a set of example EQ-5D health states
to enable a discussion of the appropriate interpretation of
the parameters.
Results
Tariff coefficients from the D1o and D1c models shared a
simple mathematical relationship: I3, I22, and I32 were
identical and the constant in the D1c model was the nega-
tive opposite of the D1 model coefficient. Using the D1
variable in place of a constant entails adding the value of
the constant to each of the 10 dummy variable coefficients.
These are not empirical results, but mathematical/logical
properties of the two models; we used empirical tests
merely to rule out logic errors. The published D1o tariff,
its D1c counterpart, and the calculation steps between the
two are listed in Table 1. The D1o and D1c tariffs resulted
in identical values for all 242 predicted EQ-5D health
states. The calculation steps for four example health states
(11111, 22222, 33133, and 33233) are shown in Table 2.
The D1o model displayed greater VIFs than the D1c
model for all predictors (see Table 1). The highest VIFs
were greater than the suggested cut-off values in both
models. In the D1c model, the I3 variable had the high-
est VIF value, at 21.2. In the D1o model, the I3 VIF
increased to 38.5, but the D1 variable VIF was substan-
tially higher, at 113.2.
Rand-Hendriksen et al. Population Health Metrics 2012, 10:2
http://www.pophealthmetrics.com/content/10/1/2
Page 3 of 6Since multicollinearity inflates the standard errors, and
the D1o model suffers from higher levels of multicolli-
nearity than the D1c model, the standard errors for the
D1c model are smaller than the ones for the D1o. Using
the D1c specification, two of the level 2 dummies (M2
and U2) were consistently statistically nonsignificant
(p < .05), while the remaining three were close to zero.
For the 10 health states describing impairments only in
a single dimension, calculation of utility values was sim-
pler when using the D1o model than when using the D1c
model; for these states, the D1 coefficient was not
invoked, meaning that the D1c model required one cal-
culation more than the D1o model. For the 40 health
states with two impaired dimensions, the two models
required the same number of calculations; the D1 vari-
able equaled the negative opposite of the D1c constant.
For the remaining 192 health states with three or more
impaired dimensions, the D1o model required more cal-
culation steps than the D1c, since the D1 coefficient had
to be multiplied by the D1 variable, an operation that is
not required for the D1c constant. While the D1o model
uses perfect health as the starting point of health state
values (1 - disutility), the calculations of D1c health state
values can be simplified by using “any impaired health
state” as the starting point ((1 - constant) -disutility, or
.860 - disutility). If the latter alternative was chosen, the
10 health states with impairment in one dimension
required the same number of calculation steps in each
model, while the remaining 232 health states required
fewer calculation steps using the D1c model.
Discussion
The D1o and D1c models are mathematically equivalent
and the two models display a simple mathematical rela-
tionship: the constant and the D1 variables are equal in
magnitude, and the dummies are shifted away from zero
by the value of the constant when it is replaced with the
D1 variable. Using the D1c specification, two of the
level 2 dummies are statistically nonsignificant.
Shifting all the dummy variable coefficients away from
zero by the value of the constant makes them pass the
test of statistical significance. Adding a regression vari-
able that shifts other parameter estimates away from
zero, thereby making them statistically significant, seems
questionable, at least when the additional complexity of
the model is not accompanied by other advantages. We
are not generally opposed to including nonsignificant
parameters in such regression models, but we must point
out that the authors of the D1 tariff excluded the I22
variable because it was statistically nonsignificant. If the
D1c specification is considered more appropriate, the I22
variable should be included or the nonsignificant dummy
variables should be excluded. Removing the nonsignifi-
cant dummies would simplify the model considerably,
while the resulting health state values would remain vir-
tually unchanged.
The VIF scores for all D1o predictors were larger than
those for their D1c counterparts. With suggested cut-offs
of somewhere between five and 10, all the predictors dis-
play questionable levels of multicollinearity using the
D1o model, while the I2 and I3 variables are questionable
Table 2 Calculation examples for the D1o and D1c tariffs
Model Health states
11111 22222 33133 33233
D1o D1c * D1o D1c * D1o D1c * D1o D1c * D1o D1c
Perfect health 1 1 1 1 1 1 1 1 1 1
Const. N/A -.140 01 -.140 1 -.140 1 -.140
M2 -.146 -.006 01 -.146 -.006 00
S2 -.175 -.035 01 -.175 -.035 00
U2 -.140 -.000 01 -.140 -.000 01 -.140 0
P2 -.173 -.032 01 -.173 -.032 00
A2 -.156 -.016 01 -.156 -.016 00
M3 -.558 -.418 001 -.558 -.418 1 -.558 -.418
S3 -.471 -.331 001 -.471 -.331 1 -.471 -.331
U3 -.374 -.234 000 00 0 00
P3 -.537 -.397 001 -.537 -.397 1 -.537 -.397
A3 -.450 -.310 001 -.450 -.310 1 -.450 -.310
I3 .122 .122 003 .366 .366 3 .366 .366
I22 -.011 -.011 01 6 -.176 -.176 00
I32 .015 .015 009 .135 .135 9 .135 .135
D1 .140 N/A 04 .560 3 .420 4 .560
Sum 1 1 .594 .594 -.100 -.100 -.100 -.100
* Multiplier.
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other variables, the D1 variable itself had a VIF of more
than 113, which is extreme in relation to the suggested
cut-offs. While the reported SE estimates for the D1c
coefficients aren’t greatly reduced as compared to the
D1o counterparts, the use of the D1o specification
increases the SE of the estimated health state values, par-
ticularly for states with impairments on multiple dimen-
sions. Consider when all five dimensions are impaired
that the D1 variable is 4. This means that the SE of the
D1 term is invoked four times, while the SE of the con-
stant (in the D1c model) is invoked only once. Thus,
using the D1c specification reduces the uncertainty
around health state estimates.
With the exception of the very mildest health states, the
D1c model required fewer calculation steps than the D1o
model. Use of the D1 variable also implies more complex
assumptions than suggested by the use of a constant; the
use of a constant implies that the observed gap between
perfect health and all other tariff values reflects a general
tendency for substantial reductions in preference for all
imperfect health states. The use of the D1 variable, on the
other hand, implies that respondents attribute specific,
additive losses in quality of life to specific impairments of
health, but that they also include large “disutility dis-
counts” to all health states where more than one dimen-
sion of health is impaired. Consider the calculations for
health state 22222 (see Table 2); compared to the D1c cal-
culations, the process of adding the constant five times
(one time for each of the five dummy coefficients), then
retracting it four times (the D1 variable) inflates the appar-
ent magnitude of the dummy coefficients, while hamper-
ing interpretation. The D1o model has, as the authors of
the US valuation study paper point out, a minor advantage
in that it simplifies the calculation of marginal utility loss
associated with single-dimension impairment. Unfortu-
nately, the inflated dummy variable coefficients obscure
two important properties of the tariff: that the utility loss
of any movement away from perfect health is dispropor-
tionally large as compared to similar movements given
other problems, and that the general public barely distin-
guishes between the five dimensions when they are at level
2 (moderate problems).
When considering the tariff algorithm, the relative mag-
nitude of the different parameters may often be inter-
preted as a measure of their relative importance. Thus, the
use of the D1o specification leads to the erroneous impres-
sion that level 2 problems are somewhere between one
half and one quarter as serious as level 3 problems. How-
ever, the inflated dummy variable coefficients in the D1o
model may systematically bias how people perceive the
tariff when presented with the calculation algorithm. From
the D1c model, it is apparent that adding level 2 problems
to any reduced health state is associated with very little
additional utility loss, except when invoking I2/I22. For
“usual activities,” the estimated utility loss of movement
from level 1 to level 2 is zero. This has the interesting
effect that, for instance, health states 33133 and 33233
have the same tariff values (see calculation examples in
Table 2). This applies to all pairs, 15 in total, of states
where “usual activities” moves from 1 to 2, while no other
dimension is at level 2 (the 16
th such pair, 11111 and
11211, is associated with a utility loss of .140, the value of
the constant).
We contend that there are numerous problems with
replacing the constant signifying any movement away
from perfect health with the D1 variable. First, it constitu-
tes a breach of the scientific guiding law of parsimony
(often referred to as Ockham’s razor), in that it introduces
new premises that unnecessarily complicate the model
without adding to its explanatory value. Second, the sub-
stitution complicates, and potentially biases, interpretation
of the tariff. Third, it obscures the fact that the dummies
representing moderate problems with mobility, usual
activities, and anxiety/depression are not significantly dif-
ferent from zero, while the two remaining level 2 dummy
coefficients are both close to zero. Finally, it obscures the
disproportionate utility loss of any movement away from
perfect health as compared to similar movements from
reduced health to further reduced health.
In this paper, we have focused on the problems related
to the way the authors of the US valuation study replaced
t h ec o n s t a n tt e r mf r o mp r e v i ous regression models with
the D1 variable. However, this is not the only alteration
they made to the regression model used in the UK valua-
tion study, in which the authors used a model consisting
of the 10-dimension dummy variables present in the D1o
model, a constant term, and dummy N3, representing the
presence of any level 3 problems. In the D1o model, the
N3 was replaced by the I3, representing the number of
dimensions at level 3, beyond the first. Substituting the
N3 with the I3 has an effect similar to the introduction of
the D1 variable, in that it inflates the values of the level 3
coefficients. Replacing the I3 variable in the D1o model
with the N3 dummy variable results in identical predicted
values for all EQ-5D health states, while further reducing
the multicollinearity of the model. The VIF for N3 would
be 3.01 when substituting the I3 in the D1c model, while
the VIFs of the other variables would remain unchanged.
Nevertheless, substituting the N3 with I3 is less proble-
matic than replacing the constant term with the D1 vari-
able, since this procedure does not alter the statistical
significance of any of the coefficients.
Conclusion
The US EQ-5D tariff would be better represented using
the D1c notification presented in this paper. While this
would not alter any of the tariff values for the EQ-5D
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iff algorithm, increase its interpretability, and make the
problems with the tariff (the disproportionate drop from
perfect health to any impaired state and the lack of dis-
tinction between level 2 impairments) more apparent.
We recommend that researchers using regression mod-
eling to calculate EQ-5D tariffs in the future avoid using
variables like the D1.
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